CPC-106 Pharmacokinetic Drug-Drug Interactions Due to Treatment with Amiodarone – a Practical Approach: Abstract CPC-106 Table 1
نویسندگان
چکیده
منابع مشابه
106 Bidzan_Layout 1
Background. The purpose of our research was to investigate the intellec tual and cognitive functions of premature babies at ten years of age. Material and methods. 35 children (15 preterm and 20 born at term) and their parents participated in the study. We used the Wechsler Intelligence Scale for Children-Revised (WISC-R) and a questionnaire containing demographic data and medical parameters. R...
متن کاملBeneficial Pharmacokinetic Drug Interactions
A drug interaction occurs when the usual effects of a drug are enhanced or diminished by another drug being taken by the patient. In most cases, these interactions are unintentional and come to the attention of clinicians due to a therapeutic failure or adverse event that is undesirable. Polypharmacy and drug interactions are common particularly among seniors. A survey of elderly individuals li...
متن کاملConfigural Processing Consortium Cpc 2016 Cpc 2016 Meeting Overview Morning
Using fMRI pattern analysis to study the part-whole relationship in the human brain
متن کاملEvaluating Pharmacokinetic Drug-Drug Interactions Due to Time-Dependent Inhibition of Cytochrome P450s
متن کامل
Evaluation of Pharmacokinetic Drug Interactions in Prescriptions of Intensive Care Unit (ICU) in a Teaching Hospital
Concomitant use of several drugs by ICU( Intensive Care Unit) patients is often unavoidable. In these patients, pharmacokinetic drug interactions are very likely. The current study was designed to evaluate these interactions in patients hospitalized in an ICU of a teaching hospital in Tehran, Iran. A questionnaire was designed and used to collect study data. The study was done in the ICU of a t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Hospital Pharmacy
سال: 2013
ISSN: 2047-9956,2047-9964
DOI: 10.1136/ejhpharm-2013-000276.563